Replies to post #405841 on NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

This is actually even more complicated from a business perspective in terms of the long term disposition of those assets in the event that NWBO is sold. But different discussion.

PM exactly that is the reason why I have been saying for weeks that LP has constructed the Avent - NWBO relation in such a manner that a future suiter will have almost no choice but to acquire Avent as well when buying NWBO.

Smart little bird LP I must say

[Jack2479]

I’m going to write to the company today and ask for member details of the conflicts committee and I then intend on writing to the chair of this committee with specific questions that hopefully will result in satisfactory answers. The way the company deals with these issues presently is they sometimes work with certain individual posters on this message board to capture shareholder sentiment and then agree responses which are vague and mostly unattributable to the company which then get posted on here often answering a question that was never asked but sometimes providing useful clarity on a situation where there is confusion. However the main purpose is to satisfy a desire for answers that mostly paint the company in a good light. In the case of Advent I’m not comfortable with the answers I got in communicating directly with Les or Dave and I’m still not reassured that the right questions have been answered from this board via any conversations between individuals. Having a conflicts committee seems like a good thing but I don’t know anything about this committee. Who appointed these individuals, do they have minuted meeting notes and is anyone on this committee outside of the current Mgt team? So hopefullly I will get a positive response to my questions and shed some light on any misunderstandings. I will keep this board updated. Thanks